Literature DB >> 28364587

Obsessive-compulsive disorder and family accommodation: A 3-year follow-up.

Juliana Braga Gomes1, Aristides Volpato Cordioli2, Elizeth Heldt2.   

Abstract

The present study assessed 3-year maintenance of family accommodation (FA) reduction in a sample from a randomized clinical trial that assessed the impact of 12 sessions of cognitive-behavioral group therapy (CBGT) for obsessive-compulsive disorder (OCD), with the involvement of family members in two sessions. Of the 46 original pairs of patients/family members, 35 were assessed at 3 years. Demographic and clinical characteristics remained similar. Post-CBGT improvement of OCD symptoms remained significant; FA reduced 39% after the therapy and 51% at follow-up. FA reduction remained over time, underscoring the importance of permanently assessing FA and involving family members when treating OCD.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive-behavioral therapy; Family accommodation; Obsessive-compulsive disorder

Mesh:

Year:  2017        PMID: 28364587     DOI: 10.1016/j.psychres.2017.03.043

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Comorbid Psychopathology and the Clinical Profile of Family Accommodation in Pediatric OCD.

Authors:  Monica S Wu; Daniel A Geller; Sophie C Schneider; Brent J Small; Tanya K Murphy; Sabine Wilhelm; Eric A Storch
Journal:  Child Psychiatry Hum Dev       Date:  2019-10

2.  Longitudinal trajectory and predictors of change in family accommodation during exposure therapy for pediatric OCD.

Authors:  Ryan J Jacoby; Hannah Smilansky; Jin Shin; Monica S Wu; Brent J Small; Sabine Wilhelm; Eric A Storch; Daniel A Geller
Journal:  J Anxiety Disord       Date:  2021-08-08

3.  The Chinese version of the family accommodation scale for obsessive-compulsive disorder self-rated: reliability, validity, factor structure, and mediating effect.

Authors:  Zhenhua Liao; Lijun Ding; Ciping You; Ying Chen; Wenchang Zhang
Journal:  Front Psychiatry       Date:  2022-08-11       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.